吉西他滨
医学
肿瘤科
内科学
临床终点
人口
奥沙利铂
化疗
随机对照试验
癌症
结直肠癌
环境卫生
作者
Zev A. Wainberg,Davide Melisi,Teresa Macarulla,Roberto Pazo-Cid,Sreenivasa R Chandana,Christelle De La Fouchardière,Andrew Dean,Igor Kišš,Woo Jin Lee,Thorsten Oliver Goetze,Eric Van Cutsem,Andrew Scott Paulson,Tanios Bekaii‐Saab,Shubham Pant,Richard Hubner,Zhimin Xiao,Huanyu Chen,Fawzi Benzaghou,Eileen M. O’Reilly
出处
期刊：The Lancet
[Elsevier BV]
日期：2023-09-11
卷期号：402 (10409): 1272-1281
被引量：186
标识
DOI：10.1016/s0140-6736(23)01366-1
摘要
Pancreatic ductal adenocarcinoma remains one of the most lethal malignancies, with few treatment options. NAPOLI 3 aimed to compare the efficacy and safety of NALIRIFOX versus nab-paclitaxel and gemcitabine as first-line therapy for metastatic pancreatic ductal adenocarcinoma (mPDAC).
科研通智能强力驱动
Strongly Powered by AbleSci AI
jenningseastera
pluto
冰魂
qiao
平常的毛豆
HEAUBOOK
bc
HEIKU
忐忑的黑猫
科研小民工
午见千山
奋斗的蜗牛
乐乐
iNk
余味
森鹿
827584450
阔达斑马
Rye227
CyrusSo524
皖公网安备34019202002308
